...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Another IPO that shocks!
4
Jan 13, 2021 02:17PM
3
Jan 13, 2021 03:30PM

...KBC,,,,,so if we are only worth .39 cents US why have these PPs been met with such a high dollar value?.....and what is the science and IP worth based by underwriters?.....not sure how other companies get a value base which merits a half billion dollars when they are just starting their research?,,hummmm,,its very odd,,,,,we are much more advanced than many of these companies which apply to list. Some I know have been private and earn revenues, most of which are a pitance but speculation in what might be is sold to the anxious buyers in their IPOs.

Nope ,,I dont see dilution as the issue,,its more along the lines of failure to acknowledge retail shareholders and hold open a path forward for insiders and acredited investing types. RVX is not on the side of retail shareholders. They are very clearly protecting inside financers for their maximum payout if that ever comes to fruition. The facts and lack of action can not be argued.

9
Jan 16, 2021 12:19PM
4
Jan 17, 2021 08:27AM
3
Jan 17, 2021 04:05PM
3
Jan 18, 2021 07:35AM
Share
New Message
Please login to post a reply